RADY CHILDRENS HOSPITAL - SAN DIEGO
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $9.4M
- Transactions
- 809
- Companies
- 40
- Average per transaction
- $11,639
Who reported the payments
| AstraZeneca | $6,284,000 |
| Amgen | $585,500 |
| Jazz Pharmaceuticals Inc. | $422,927 |
| Soleno Therapeutics, Inc. | $308,112 |
| Merck | $233,888 |
| Ionis Pharmaceuticals, Inc. | $208,302 |
| AbbVie | $190,587 |
| Pfizer | $149,561 |
| E.r. Squibb & Sons, L.L.C. | $142,666 |
| Siemens Medical Solutions USA, Inc. | $110,519 |
| Orthopediatrics Corp. | $92,351 |
| Boehringer Ingelheim | $68,069 |
| Kls-martin L.p. | $55,959 |
| Takeda Pharmaceuticals U.S.A., Inc. | $51,827 |
| National Marrow Donor Program | $48,415 |
| Medtronic | $48,191 |
| BD | $44,580 |
| Novo Nordisk AS | $32,960 |
| Travere Therapeutics, Inc. | $30,500 |
| Med-el Corporation | $29,080 |
| Tolmar, Inc. | $26,063 |
| KARL Storz Endoscopy-america | $23,210 |
| Stryker | $20,083 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $18,830 |
| Dermira, Inc. | $15,250 |
| Daiichi Sankyo Inc. | $13,609 |
| Bristol Myers Squibb | $13,000 |
| Nabriva Therapeutics, PLC | $10,465 |
| Incyte Corporation | $10,433 |
| Grifols Therapeutics LLC | $10,359 |
| Abbott | $8,750 |
| Linvatec Corporation | $8,495 |
| Cochlear Americas | $7,759 |
| Novo Nordisk | $6,413 |
| Eli Lilly | $5,459 |
| Novartis | $5,411 |
| Edwards Lifesciences | $5,306 |
| B. Braun Medical Inc. | $5,018 |
| Chiesi USA, Inc. | $5,000 |
| Regeneron Healthcare Solutions, Inc. | $5,000 |